Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Darby

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Lancet (London, England)|December 14, 2011
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials, R Peto, C Davies, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 15, 2016
Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK AuditJ King, D H Palmer, P Johnson, et al.
ESMO Open|July 13, 2024
Maintenance durvalumab after first-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM studyC Fong, B Patel, C Peckitt, et al.
BMJ (Clinical Research Ed.)|December 23, 2004
Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studiesS Darby, D Hill, A Auvinen, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Lancet (London, England)|December 14, 2011
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials, R Peto, C Davies, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 15, 2016
Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK AuditJ King, D H Palmer, P Johnson, et al.
ESMO Open|July 13, 2024
Maintenance durvalumab after first-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM studyC Fong, B Patel, C Peckitt, et al.
BMJ (Clinical Research Ed.)|December 23, 2004
Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studiesS Darby, D Hill, A Auvinen, et al.
Pageof 7